↓ Skip to main content

Dove Medical Press

A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis…

Overview of attention for article published in Therapeutics and Clinical Risk Management, December 2008
Altmetric Badge

Mentioned by

policy
1 policy source

Readers on

mendeley
50 Mendeley
Title
A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India
Published in
Therapeutics and Clinical Risk Management, December 2008
DOI 10.2147/tcrm.s3581
Pubmed ID
Authors

Vidya Nand Rabi Das, Niyamat Ali Siddiqui, Krishna Pandey, Vijay Pratap Singh, Roshan K Topno, Dharmendra Singh, Rakesh Bihari Verma, Alok Ranjan, Prabhat Kumar Sinha, Pradeep Das

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Belgium 2 4%
United States 1 2%
United Kingdom 1 2%
Unknown 46 92%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 20%
Student > Bachelor 6 12%
Student > Ph. D. Student 5 10%
Student > Master 5 10%
Student > Doctoral Student 4 8%
Other 6 12%
Unknown 14 28%
Readers by discipline Count As %
Medicine and Dentistry 12 24%
Agricultural and Biological Sciences 7 14%
Biochemistry, Genetics and Molecular Biology 3 6%
Chemistry 3 6%
Nursing and Health Professions 2 4%
Other 9 18%
Unknown 14 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2016.
All research outputs
#8,534,976
of 25,373,627 outputs
Outputs from Therapeutics and Clinical Risk Management
#461
of 1,323 outputs
Outputs of similar age
#51,509
of 179,596 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#6
of 18 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 179,596 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.